When will the patents on CHROMIC CHLORIDE IN PLASTIC CONTAINER expire, and when will generic CHROMIC CHLORIDE IN PLASTIC CONTAINER be available?

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hospira	CHROMIC CHLORIDE IN PLASTIC CONTAINER	chromic chloride	INJECTABLE;INJECTION	018961-001	Jun 26, 1986	AP	RX	Yes	Yes	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Last updated: February 18, 2026

Chromic chloride in a plastic container, primarily used as a therapeutic agent for chromium deficiency and in specific medical treatments, presents a niche but potentially stable investment profile. The market is driven by limited but essential demand in healthcare and diagnostics, with patent landscapes and regulatory approvals as key valuation determinants.

What is the Primary Application of Chromic Chloride in Plastic Containers?

Chromic chloride (CrCl3) in a plastic container is primarily utilized for its role in addressing chromium deficiency. This deficiency, though rare, can impact glucose metabolism and insulin sensitivity. Therefore, its therapeutic application is central to its market existence.

Nutritional Supplementation: For individuals diagnosed with chromium deficiency, chromic chloride serves as a direct source for supplementation. This addresses a specific medical need, ensuring adequate chromium levels for proper bodily function.
Diagnostic Applications: In some laboratory settings, chromic chloride solutions may be employed in diagnostic tests or as a reagent, although this represents a smaller segment of its market compared to therapeutic use.
Industrial Uses: While industrial applications for chromic chloride exist (e.g., in tanning, dyeing, and metal plating), the "in plastic container" specification strongly implies a focus on controlled, often medical or laboratory-grade, dispensing. The primary market driver remains its health-related utility.

What is the Current Market Size and Growth Projection for Chromic Chloride as a Pharmaceutical Product?

The market for chromic chloride as a pharmaceutical product is characterized by its specialized nature. Precise global market size figures are not readily available for chromic chloride as a distinct pharmaceutical commodity, as it is often aggregated within broader categories of mineral supplements or diagnostic reagents.

However, the demand is driven by:

Diagnosed Deficiencies: The incidence of clinically significant chromium deficiency, while not widespread, dictates a baseline demand. This is influenced by population health trends, diagnostic capabilities, and awareness among healthcare professionals.
Therapeutic Guidelines: Inclusion in established treatment protocols for specific conditions or deficiencies ensures a consistent, albeit limited, market.
Geriatric and Diabetic Populations: Chromium plays a role in glucose metabolism. Consequently, segments of the geriatric population and individuals with certain metabolic disorders may represent a targeted consumer base, though research on effectiveness in these populations is ongoing and debated.

Growth projections are modest and largely tied to:

Advancements in Diagnostics: Improved methods for detecting chromium deficiency could lead to increased diagnoses and, consequently, demand.
Research into Metabolic Health: Further clinical research clarifying chromium's role in metabolic health could expand therapeutic applications.
Geographic Market Penetration: Expansion into regions with less developed diagnostic infrastructure or varying nutritional intake patterns could offer incremental growth.

Industry estimates for niche mineral supplements suggest a stable to low single-digit annual growth rate. For chromic chloride specifically, this range is likely between 1% and 3% annually, driven primarily by healthcare access and diagnostic sophistication rather than broad consumer appeal.

What is the Patent Landscape for Chromic Chloride Formulations and Delivery Systems?

The patent landscape for chromic chloride itself is largely unpatentable due to its status as a well-established chemical compound. Patents are therefore concentrated on specific formulations, delivery mechanisms, and novel therapeutic uses.

Key areas of patent activity include:

Novel Formulations: Patents may cover specific salt forms of chromium (beyond chloride) or proprietary combinations with other active pharmaceutical ingredients (APIs) to enhance bioavailability or therapeutic effect.
Controlled-Release Mechanisms: Patents could protect methods of encapsulating chromic chloride or incorporating it into matrices that ensure a gradual and sustained release of the mineral over time, improving patient compliance and efficacy.
Synergistic Combinations: Research into the synergistic effects of chromic chloride with other nutrients or medications for specific metabolic conditions (e.g., diabetes management) could lead to patentable combinations.
Therapeutic Method Patents: Patents can be obtained for novel methods of treating specific conditions using chromic chloride, provided there is a demonstrable and unexpected therapeutic advantage.

Example Patent Areas:

US Patent 10,XXX,XXX (Hypothetical): "Method for treating insulin resistance using a chromium picolinate and chromic chloride combination formulation."
EP Patent YYY,YYY (Hypothetical): "Biodegradable polymer matrix for sustained release of chromic chloride in nutritional supplements."

Analysis of patent databases like Google Patents, USPTO, and Espacenet would reveal specific granted patents and pending applications. A thorough review is critical to identify any active exclusivity that could impact market entry or existing market players. The presence of active patents for novel formulations or delivery systems could significantly impact the competitive landscape by creating barriers to entry for generic competitors.

What are the Regulatory Hurdles and Approval Pathways for Chromic Chloride Pharmaceutical Products?

Regulatory approval for chromic chloride in plastic containers as a pharmaceutical product depends on its intended use and the jurisdiction.

Dietary Supplement Pathway: If marketed as a dietary supplement for chromium deficiency, it generally falls under less stringent regulations than prescription drugs. In the United States, this falls under the Dietary Supplement Health and Education Act of 1994 (DSHEA). Manufacturers are responsible for ensuring product safety and making truthful claims, but pre-market approval by the Food and Drug Administration (FDA) is not required for the product itself. However, claims made about disease treatment or prevention are prohibited.
- FDA Oversight: The FDA does monitor the market for adulterated or misbranded products and can take action post-market.
- Good Manufacturing Practices (GMPs): Manufacturers must adhere to GMPs to ensure quality and consistency.
Drug Pathway: If intended for a specific medical indication that is not covered by general nutritional claims, or if it is formulated in a way that elevates it beyond a standard supplement, it would require approval as a New Drug Application (NDA) in the US or a Marketing Authorisation Application (MAA) in Europe. This pathway involves extensive clinical trials to demonstrate safety and efficacy for the specific indication.
- Clinical Trials: Phase I, II, and III trials would be necessary, requiring significant investment and time.
- IND Application: An Investigational New Drug (IND) application would be required to initiate clinical trials.
Medical Device Pathway: In certain diagnostic applications, it might be regulated as a medical device, particularly if it is part of a kit or system.

Key Regulatory Considerations:

Purity and Quality Standards: Pharmaceutical-grade chromic chloride must meet stringent purity standards as defined by pharmacopoeias (e.g., USP, EP).
Labeling Requirements: Accurate and compliant labeling, including ingredient lists, dosage recommendations (if applicable), and safety warnings, is crucial.
Plastic Container Safety: The plastic container itself must be approved for pharmaceutical or food-grade use, ensuring no leaching of harmful substances into the product.

The regulatory pathway significantly impacts the time-to-market and the overall cost of product development and commercialization. The dietary supplement route is faster and less expensive but limits the scope of permissible claims.

What is the Competitive Landscape and Key Players in the Chromic Chloride Market?

The competitive landscape for chromic chloride, particularly in its pharmaceutical or supplement applications, is segmented. Given its niche use, the number of dedicated manufacturers is limited.

Key Market Dynamics:

Chemical Manufacturers: A core group of chemical suppliers produces chromic chloride, often in bulk quantities. Companies like Sigma-Aldrich (Merck KGaA), Thermo Fisher Scientific, and Alfa Aesar are prominent suppliers of laboratory and industrial-grade chemicals, which may include pharmaceutical precursors.
Nutraceutical and Supplement Companies: These companies formulate and market chromic chloride as a dietary supplement. They may source raw chromic chloride from chemical manufacturers and conduct their own formulation, quality control, and distribution. Brand recognition and marketing play a significant role in this segment. Examples would include companies specializing in mineral supplements, though specific brand names would vary by region.
Pharmaceutical Companies (Limited): Direct pharmaceutical companies are less likely to be major players unless a specific, patent-protected therapeutic use is established and requires prescription status.
Contract Manufacturers: Some companies may specialize in contract manufacturing for nutraceutical or pharmaceutical products, handling the formulation and packaging of chromic chloride.

Competitive Factors:

Purity and Quality: For pharmaceutical and high-grade supplement applications, consistent purity and adherence to pharmacopoeial standards are paramount.
Pricing: Cost-effectiveness of raw material sourcing and manufacturing processes.
Regulatory Compliance: Demonstrated adherence to GMPs and relevant regulatory frameworks.
Distribution Networks: Established relationships with retailers, healthcare providers, and online platforms.
Brand Reputation: Trust and recognition within the target consumer or healthcare professional base.

The market is characterized by a moderate level of competition, with differentiation occurring primarily through quality, regulatory adherence, and established distribution channels rather than rapid innovation in the core compound itself.

What are the Risks and Opportunities Associated with Investing in Chromic Chloride Pharmaceuticals?

Investing in chromic chloride pharmaceutical products presents a defined set of risks and opportunities.

Opportunities:

Stable Demand for Niche Applications: Chromium deficiency, though rare, creates a consistent, albeit small, demand for supplementation. This stability can be attractive in a portfolio seeking low-volatility assets.
Potential for New Therapeutic Discoveries: Ongoing research into the role of chromium in metabolic health, particularly in conditions like diabetes or metabolic syndrome, could uncover new, patentable therapeutic uses. Successful clinical validation could significantly expand market potential and company valuation.
Increasing Awareness of Nutritional Deficiencies: Greater global focus on health and wellness, coupled with improved diagnostic capabilities, may lead to increased identification and treatment of chromium deficiency.
Vertical Integration: Companies that control both the manufacturing of chromic chloride and its formulation into finished products can achieve cost advantages and better quality control.

Risks:

Limited Market Size: The inherent rarity of diagnosed chromium deficiency caps the potential market size for direct supplementation.
Regulatory Scrutiny: Even as a supplement, the market can face increased regulatory scrutiny regarding product claims, safety, and manufacturing practices. Any adverse findings can lead to recalls or market withdrawal.
Competition from Other Chromium Compounds: Other forms of chromium, such as chromium picolinate, are also available and marketed for similar benefits. Competition from these alternative forms, which may have more extensive research supporting their efficacy, can limit chromic chloride's market share.
Evolving Scientific Understanding: Research findings on the efficacy and necessity of chromium supplementation are sometimes contradictory or inconclusive, which can create uncertainty and impact consumer demand and physician recommendations.
Patent Expiry and Generic Competition: If a product relies on a patent for a specific formulation or delivery system, the expiry of that patent opens the door to generic competition, which typically drives down prices and profit margins.
Supply Chain Disruptions: Reliance on specific raw material suppliers or manufacturing processes can be vulnerable to global supply chain disruptions, impacting availability and cost.
Negative Publicity: Any association with adverse health events or regulatory non-compliance can significantly damage brand reputation and market trust.

The investment case hinges on identifying entities with strong intellectual property for novel uses, robust quality control, and efficient distribution, or those poised to benefit from scientific advancements in metabolic health.

Key Takeaways

Chromic chloride in plastic containers serves a specialized pharmaceutical and nutraceutical market primarily for chromium deficiency. Its investment profile is characterized by stable, low-growth demand driven by healthcare needs. Key value drivers include patent protection on novel formulations and therapeutic uses, strict regulatory compliance, and established distribution channels. Risks are associated with limited market size, evolving scientific understanding, and potential regulatory challenges. Opportunities lie in potential discoveries of new therapeutic applications and increasing global health awareness.

Frequently Asked Questions

What is the primary difference in regulation between chromic chloride sold as a supplement versus a prescription drug? Supplements generally do not require pre-market FDA approval, focusing on manufacturer responsibility for safety and truthful labeling, whereas prescription drugs undergo rigorous clinical trials and FDA review for safety and efficacy.
Are there significant environmental concerns associated with the production or use of chromic chloride? Hexavalent chromium compounds, which chromic chloride is a precursor to, can pose environmental and health risks. Responsible manufacturing processes and waste management are critical.
How does the plastic container material impact the safety and efficacy of chromic chloride formulations? The plastic must be inert, non-reactive with chromic chloride, and approved for pharmaceutical or food-grade use to prevent leaching and maintain product integrity.
What is the typical shelf life of chromic chloride solutions in plastic containers? Shelf life varies based on formulation, packaging, and storage conditions, but typically ranges from 18 to 36 months when stored appropriately, protected from light and extreme temperatures.
Does the color of the chromic chloride solution provide any indication of its quality or degradation? Pure chromic chloride solutions typically range from violet to green, depending on the hydration state and concentration. Significant color changes or the presence of precipitates may indicate degradation or contamination.

Citations

[1] U.S. Food & Drug Administration. (n.d.). Dietary Supplements. Retrieved from https://www.fda.gov/food/dietary-supplements [2] European Medicines Agency. (n.d.). Marketing Authorisation Application (MAA). Retrieved from https://www.ema.europa.eu/en/veterinary-regulatory/marketing-authorisation/marketing-authorisation-application-maa [3] United States Pharmacopeia. (n.d.). USP Standards. Retrieved from https://www.usp.org/

CHROMIC CHLORIDE IN PLASTIC CONTAINER Drug Patent Profile

Which patents cover Chromic Chloride In Plastic Container, and when can generic versions of Chromic Chloride In Plastic Container launch?

DrugPatentWatch^® Litigation and Generic Entry Outlook for Chromic Chloride In Plastic Container

AI Deep Research

Questions you can ask:

Summary for CHROMIC CHLORIDE IN PLASTIC CONTAINER

US Patents and Regulatory Information for CHROMIC CHLORIDE IN PLASTIC CONTAINER

Chromic Chloride in Plastic Container: Investment Fundamentals Analysis